Gating of Social Reward by Oxytocin in the Ventral Tegmental Area
Featuring
-
Robert Malenka
SFARI Investigator
Bringing people and ideas together to fund, conduct, and share transformative science.
Our grants advance knowledge and strengthen connections between science and society.
Discover the latest news, research, and updates.
We convene scientists, mathematicians, and thinkers to share ideas and explore new questions.
Founded by Jim and Marilyn Simons, we’re a private philanthropy advancing mathematics and basic science.
Work with us on the frontier of basic science research.
The Flatiron Institute is a research center that uses computational science to advance fields like physics, biology, and astronomy.
Search
Robert Malenka and colleagues find that oxytocin acts within the ventral tegmental area to increase dopamine reward neurons to reinforce the rewarding aspects of social interactions in mice.
SFARI Investigator
Animal studies have shown that the neuropeptide oxytocin (OXT) acts within the nucleus accumbens (NAc), a reward circuitry brain region, to help promote the positive effects of prosocial interactions. In mouse models of autism, administration of OXT also appears to reduce social deficits. How exactly OXT exerts its effects on the brain reward circuitry to reinforce prosocial interactions as rewarding, however, has remained unclear, thus making it difficult to understand how these findings in mice might be translated to possible treatments for individuals with autism. In a recent article, SFARI Investigators Robert Malenka, Liqun Luo, Karl Deisseroth and their colleagues report that OXT acts directly upon the dopaminergic neurons of the ventral tegmental area (VTA) to mediate social reward. Using in vivo activation and inhibition experiments in mice, the authors demonstrate that social interactions cause an increase in OXT release from paraventricular nucleus neurons into the VTA. This OXT then modulates the reward circuitry by increasing excitatory drive onto VTA dopamine neurons, reinforcing the rewarding aspects of social behaviors. These findings provide key mechanistic insights into the effects of OXT in the brain and a step in understanding whether OXT therapeutics might eventually be possible in humans.